Does RANOLAZINE Cause Mobility decreased? 12 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Mobility decreased have been filed in association with RANOLAZINE (Ranolazine). This represents 0.1% of all adverse event reports for RANOLAZINE.
12
Reports of Mobility decreased with RANOLAZINE
0.1%
of all RANOLAZINE reports
0
Deaths
7
Hospitalizations
How Dangerous Is Mobility decreased From RANOLAZINE?
Of the 12 reports, 7 (58.3%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Stent placement (593)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which RANOLAZINE Alternatives Have Lower Mobility decreased Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ